RedHill Biopharma secures FDA approval for Talicia to treat H pylori infection in adults

This article was originally published here

RedHill said that its Talicia has been indicated for oral administration in the form of delayed-release capsules in 10mg, or 250mg or in 12.5mg dosage. RedHill Biopharma chief

The post RedHill Biopharma secures FDA approval for Talicia to treat H pylori infection in adults appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply